Everything below concerns regulatory status. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-11-16. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Peptide fragment | Corresponds to hGH residues 176-191 |
| Common synonyms | AOD9604, hGH 176-191 | Also written as AOD-9604 |
| Typical form | Lyophilized powder | Often supplied in sealed vials |
| Solubility | Water-soluble | Dissolves in aqueous buffers |
| Regulatory status | Not approved as drug | Banned in sport; varies by country |
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
=== Board positions === Thomsen has held several leadership and advisory positions in academia and industry. Additionally, he has served as chairman of the Danish Biotech Research and Innovation Centre and has participated in governmental committees related to post-graduate education reforms in Denmark.
==== Menstrual bleeding ==== Menstrual bleeding is a common cause of iron deficiency anemia in women of childbearing age. Women with menorrhagia (heavy menstrual periods) are at risk of iron deficiency anemia because they are at a higher than normal risk of losing more iron during menstruation than is replaced in their diet. Most women lose about 40 mL of blood per cycle. Some birth control methods, such as pills and IUDs, may decrease the amount of blood and therefore iron lost during a menstrual cycle. Intermittent iron supplementation may be as effective a treatment in these cases as daily supplements and reduce some of the adverse effects of long-term daily supplements.
=== Artificial satellite development === In 1955, with both the United States and the Soviet Union building ballistic missiles that could be used to launch objects into space, the stage was set for nationalistic competition. On July 29, 1955, James C. Hagerty, President Dwight D. Eisenhower's press secretary, announced that the United States intended to launch "small Earth circling satellites" between July 1, 1957, and December 31, 1958, as part of the US contribution to the International Geophysical Year (IGY). On August 2, at the Sixth Congress of the International Astronautical Federation in Copenhagen, scientist Leonid I. Sedov told international reporters at the Soviet embassy of his country's intention to launch a satellite as well, in the "near future".
Sources: en.wikipedia.org
=== Nigeria === To combat money laundering, the Economic and Financial Crimes Commission was established in 2003. This body works alongside the Central Bank of Nigeria and the National Drug Law Enforcement Agency, to investigate and prosecute, individuals charged with the crime. The Money laundering Act was also established in 2011. This act contains elaborate provisions on the legal and institutional framework to prevent money laundering. The act also established the Special Control Unit against Money Laundering, under the EFCC. This act made key changes to the repealed act, some of which are;
== Early life == Phang grew up in the San Francisco Bay Area. She was born in Berkeley, California and is of mixed Chinese Malaysian and Vietnamese heritage. She graduated from Pomona College with a Bachelor of Arts in Media Studies, and also graduated from the American Film Institute with a Masters of Fine Arts (M.F.A.) in Film Directing. She has also participated in the San Francisco Film Society Women Filmmaker Fellowship. In 2008, Phang was named as one of the "25 new Faces of Independent Film" by Filmmaker Magazine. In 2015, she was selected as one of six Women at Sundance Fellows. In 2016 she was also selected for the Warner Bros. Television Directors' Workshop where she met the director/producer of Breaking Bad and Game of Thrones, Michelle MacLaren, who became her mentor.
These include radionuclides occurring in the decay chains of primordial uranium and thorium (radiogenic nuclides), such as radon-222. Others are the products of interactions with energetic cosmic rays (the cosmogenic nuclides), such as carbon-14. This gives a total of about 350 naturally occurring nuclides, some of which are difficult to detect. Other nuclides may be occasionally produced naturally by rare cosmogenic interactions or as a result of other natural nuclear reactions (nucleogenic nuclides), and these are generally even less detectable. Non-primordial nuclides may also be detected in the spectra of stars; technetium is well established, and others have been claimed. The remaining nuclides are known solely from artificial nuclear transmutations. Some, such as caesium-137 and krypton-85, are detected in the environment, but only (or practically only) from deliberate or accidental release of artificial production, as fission products (from nuclear weapons or nuclear reactors), for industrial or medical uses, or otherwise.
==== Trophic interactions ==== Assimilation of diet into tissue has a tissue-specific fractionation known as the trophic discrimination factor. Diet sources can be tracked through a food web via deuterium isotope profiles, though this is complicated by deuterium having two potential sources – water and food. Food more strongly impacts δD than does exchange with surrounding water, and that signal is seen across trophic levels. However, different organisms derive organic hydrogen in varying ratios of water to food: for example, in quail, 20-30% of organic hydrogen was from water and the remainder from food. The precise percentage of hydrogen from water, depended on tissue source and metabolic activity. In chironomids, 31-47% of biomass hydrogen derived from water, and in microbes as much as 100% of fatty acid hydrogen can be derived from water depending on substrate. In caterpillars, diet δD from organic matter correlates linearly with tissue δD. The same relationship does not appear to hold consistently for diet δD from water, however – water derived from either the caterpillar or its prey plant is more 2H-enriched than their organic material. Going up trophic levels from prey (plant) to predator (caterpillar) results in an isotopic enrichment. This same trend of enrichment is seen in many other animals - carnivores, omnivores, and herbivores - and seems to follow 15N relative abundances. Carnivores at the same trophic level tend to exhibit the same level of 2H enrichment.
Sources: en.wikipedia.org
== Extraction == β-glucan extraction from oat can be difficult due to tendency of depolymerization – which often occurs in high pH. Thus β-glucan extraction is usually performed under a more neutral pH and generally at temperatures of 60–100 °C (140–212 °F). Usually β-glucan is solubilized in the extraction process with residual starch, which is then removed by hydrolysis with alpha-amylase. The residual solution usually contains coextracts of hemicelluloses and proteins which can then be separated through selective precipitation. Through wet milling, sieving, and solvent-extraction, oat beta-glucans can achieve up to 95% extraction purity.
== Plasticity == Cell plasticity is the idea that cells can switch phenotypes in response to environmental cues. In the context of regeneration, this environmental cue is damage or injury to a limb. Cell plasticity is closely related to dedifferentiation, implying that a cell with ‘plasticity’ can dedifferentiate to change phenotypes. Cell plasticity suggests that cells can change phenotypes slightly; not fully de-differentiating, to serve a better function. A strong example of this is lens regeneration in the newt.
Thomas Cashman, 34, is convicted of shooting dead nine-year-old Olivia Pratt-Korbel in her Liverpool home in August 2022. The Parliamentary Standards Committee recommends that former Scottish National Party MP Margaret Ferrier be suspended from the House of Commons for 30 days for breaching COVID-19 regulations in September 2020 when she took a train home from London following a positive COVID test. 31 March Figures released by the Office for National Statistics show an 0.1% growth in the UK economy for the final three months of 2022, revising previous figures that had suggested no growth over that period. COVID-19 in the UK: The UK Health Security Agency confirms the NHS COVID-19 contact tracing app will close on 27 April following a decline in its use.
=== Analytical implementations === Surface plasmon resonance can be implemented in analytical instrumentation. SPR instruments consist of a light source, an input scheme, a prism with analyte interface, a detector, and computer. Any quantitative derivation relies on modelling the surface based on the boundary conditions of the Maxwell's equations, for plane films using the Fresnel equations.
=== April === 1 April – The Hate Crime and Public Order (Scotland) Act 2021, which creates a new crime of "stirring up hatred" relating to age, disability, religion, sexual orientation, transgender identity or being intersex, comes into force in Scotland. 2 April – The Scottish Government publishes a consultation on legislation to ban egg producers from housing chickens in cages in Scotland. Police Scotland says that comments challenging Scotland's new hate crime law made by the author J K Rowling are not being treated as a crime. 6 April – Changes to Income tax in Scotland come into force, with a new "Advanced" rate for those earning over £75,000. 8 April – Ritlecitinib, provided under the brand name Litfulo and used to treat the most common forms of alopecia, is licensed for use by the NHS in Scotland. Father and son Ian and Dean McLeod are sentenced to life imprisonment with minimum terms of 34 years for the 2022 murders of Derek Johnston and Desmond Rowlings with the use of a blowtorch at a flat in Edinburgh. 9 April – Former NHS worker Tracy Menhinick is sentenced to seven years in prison after poisoning a young boy with "industrial" amounts of laxative. 10 April – Police Scotland says it received 7,000 online reports of alleged hate crimes during the first week of new laws enacted by the Hate Crime and Public Order (Scotland) Act. 11 April – Glasgow is named as a potential host of the 2026 Commonwealth Games following Victoria's July 2023 decision to withdraw as host because of rising costs.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.
No, it is a small fragment of the full growth hormone protein. It does not appear to stimulate growth or increase growth hormone levels in the same way. Its actions are thought to be more limited to metabolic pathways.
Regulatory status varies. It is not approved for medical use in the United States or many other countries. It is banned in sport by WADA, and its sale as a supplement or research chemical may be subject to legal restrictions.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.